REVELATION BIOSCIENCES INC COM 2025
REVELATION BIOSCIENCES INC COM 2025 is a security (CUSIP 76135L804) tracked across SEC portfolio filings. 10 institutional managers reported $584K on Form 13F as of 2026-06-30; 1 registered fund positions totaling $60 via N-PORT as of 2026-03-31.
Summary
- Issuer: REVELATION BIOSCIENCES INC
- Class: COM 2025
- CUSIP: 76135L804
- Asset category: EC
- 13F holders: 10
- 13F value: $584K
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $60
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| ARMISTICE CAPITAL, LLC | NEW YORK, NY | $388K | 323,241 |
| SABBY MANAGEMENT, LLC | Spicewood, TX | $119K | 99,432 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $52K | 43,195 |
| XTX Topco Ltd | LONDON, X0 | $14K | 11,385 |
| UBS Group AG | Zurich, V8 | $5K | 4,115 |
| Tower Research Capital LLC (TRC) | NEW YORK, NY | $5K | 4,074 |
| Royal Bank of Canada | TORONTO, A6 | $1K | 747 |
| SBI Securities Co., Ltd. | TOKYO, M0 | $354 | 344 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | Paris, I0 | $11 | 9 |
| Caitong International Asset Management Co., Ltd | HONG KONG, K3 | $1 | 1 |
Top fund holders (N-PORT)
More